# DESCRIPTION

## FIELD OF THE INVENTION

- relate to pharmaceutical compositions and methods

## BACKGROUND

- describe hypertrophic scar reduction challenges
- discuss fibrosis and wound healing process

## DESCRIPTION OF THE INVENTION

- introduce siRNA molecule composition
- describe siRNA molecule structure
- define siRNA molecule function
- discuss siRNA molecule modifications
- describe siRNA molecule length
- introduce histidine-lysine co-polymer carrier
- describe nanoparticle formation
- discuss siRNA molecule selection process
- introduce animal wound models
- describe siRNA molecule evaluation process
- discuss siRNA molecule targeting
- introduce pharmaceutical composition administration
- describe fibroblast and myofibroblast apoptosis activation
- discuss hypertrophic scar size reduction
- describe fibrosis reduction

## EXAMPLES

### Example 1: Simultaneous Silencing of TGF-β1 and COX-2 Gene Expressions

- design siRNA sequences

### Example 2: Simultaneous Silencing of TGF-β1 and COX-2 Gene Expressions Resulted in Activation of Apoptosis of Fibroblasts/Myofibroblasts

- investigate fibroblast fate

### Example 3. HKP Enhances siRNA Delivery Into Human Hypertrophic Scar

- select HKP for siRNA delivery

### Example 4. HKP-Packaged TGF-β1/COX-2siRNA Reduces Size of Human Hypertrophic Scar

- study TGF-β1 and COX-2 expression
- evaluate HKP treatment effect

### Example 5. HKP (TGF-β1/COX-2siRNAs) Reduces Size of Human Skin Grafts

- study HKP treatment effect on skin grafts

### Example 6. HKP (TGF-β1/COX-2siRNAs) Demonstrates a Novel Anti-Fibrotic Mechanism of Action

- investigate underlying biology

### Example 7. HKP (TGF-β1/COX-2 siRNAs) Induced Apoptotic Activities of the Fibroblast/Myofibroblasts In Vivo

- measure apoptotic activity

### Example 8. HKP (TGF-β1/COX-2 siRNAs) Serves as a Novel Anti-Fibrotic Therapeutic Agent

- propose therapeutic approach

## Discussion

- introduce wound healing process
- discuss fibroblast role
- discuss TGF-β1 and COX-2 regulation
- evaluate HKP (siRNA) nanoparticle formulation
- discuss therapeutic benefits

## Materials and Methods

### siRNA Sequence Design and Selection

- design siRNA duplexes

### Growth Inhibition In Vitro

- perform growth inhibition assay

### Nanoparticle Preparation

- prepare HKP nanoparticles

### Mouse

- describe mouse model

### Human Hypertrophic Scar and Skin Tissue Implant Models

- describe human tissue implant models

### Therapeutic Evaluation with the Human Tissue Implant Models

- evaluate therapeutic effect

### Statistical Analysis

- describe statistical analysis

